-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gastroesophageal reflux disease (GERD) is often accompanied by painful symptoms and serious complications, and in recent years, the diagnosis of GERD has become increasingly common in children, and acid-suppressing drugs (ASMs) have been prescribed, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RA).
The objective of this study was to determine the incidence, prevalence, and relationship
to key variables in the diagnosis and treatment of gastroesophageal reflux disease (GERD) in children with nerve injury (NI).
The primary outcomes were the incidence and prevalence of GERD diagnosis: (1) hospital-based ICD-10 code; (2) expert statements; (3) Distribution
of acid-lowering drugs (ASM).
The results found that of 10,309 NI children, 2,772 (26.
Association of CCC and TA with the incidence of ASM treatment
Overall, this study found that the incidence of GERD in NI children greatly exceeds that of the general pediatric population, and likewise, the incidence of drug distribution is closer to that of adults, especially those
with multiple CCCs and gastrostomy tubes.
References: Dewan T, Turner J, Lethebe BC, et al.
